Genetic risk factors for infection in patients with early rheumatoid arthritis taking etanercept or methotrexate.

被引：0
|
作者：
Hughes, LB
Criswell, LA
Beasley, TM
Edberg, JC
Kimberly, RP
Moreland, LP
Seldin, LF
Bridges, SL
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [21] Study Completion and Etanercept Retention in Patients with Rheumatoid Arthritis Treated with Etanercept or Etanercept and Methotrexate in the CAnadian Methotrexate and Etanercept Outcome (CAMEO) Study
    Pope, Janet
    Keystone, Ed
    Thorne, Carter
    Poulin-Costello, Melanie
    Phan-Chronis, Krystene
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1239 - 1240
  • [22] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis (vol 343, pg 1586, 2000)
    Bathon, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03): : 240 - 240
  • [23] Raised ALT in patients taking methotrexate for rheumatoid arthritis
    Horne, A.
    Vadiveloo, T.
    Tan, S.
    Guthrie, B.
    Pullar, T.
    SCOTTISH MEDICAL JOURNAL, 2015, 60 (03) : E28 - E28
  • [24] Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis
    Gerards, AH
    de Lathouder, S
    de Groot, ER
    Dijkmans, BAC
    Aarden, LA
    RHEUMATOLOGY, 2003, 42 (10) : 1189 - 1196
  • [25] Studies of Disease and Therapy-Response Biomarkers in Early Rheumatoid Arthritis Treated with Methotrexate.
    Hensvold, Aase Haj
    Saevarsdottir, Saedis
    Li, Wanyiang
    Malmstrom, Vivianne
    Cavet, Guy
    Klareskog, Lars
    Catrina, Anca Irinel
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S901 - S901
  • [26] Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?
    Luzi, G.
    Lagana, B.
    Salemi, S.
    Di Rosa, R.
    CLINICA TERAPEUTICA, 2009, 160 (02): : 121 - 123
  • [27] Factors influencing length of time taking methotrexate in rheumatoid arthritis
    Ortendahl, M
    Schettler, JD
    Fries, JF
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (05) : 1139 - 1147
  • [28] THE RISK FACTORS OF SERIOUS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hasegawa, E.
    Kobayashi, D.
    Ito, S.
    Narita, I.
    Nakazono, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
  • [29] Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
    Sylejman Rexhepi
    Mjellma Rexhepi
    Blerta Rexhepi
    Vjollca Sahatçiu-Meka
    Vigan Mahmutaj
    Arthritis Research & Therapy, 14 (Suppl 1):
  • [30] Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
    Rexhepi, Sylejman
    Rexhepi, Mjellma
    Rexhepi, Blerta
    Sahatciu-Meka, Vjollca
    Mahmutaj, Vigan
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
12345